Immucell Corp (ICCC) Reports Q2 EPS of $0.03
Tweet
Share
E-mailGet Alerts ICCC Hot Sheet
Join SI Premium – FREE
Immucell Corp (NASDAQ: ICCC) reported Q2 EPS of $0.03, versus ($0.10) reported last year. Revenue for the quarter came in at $1.96 million, versus $1.54 million reported last year.
For earnings history and earnings-related data on Immucell Corp (ICCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Vertex to acquire Crinetics Pharmaceuticals for $10 billion
- ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
